Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.
about
Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions.Arrhythmogenic cardiomyopathyArrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular diseaseMutations with pathogenic potential in proteins located in or at the composite junctions of the intercalated disk connecting mammalian cardiomyocytes: a reference thesaurus for arrhythmogenic cardiomyopathies and for Naxos and Carvajal diseasesArrhythmogenic right ventricular dysplasia/cardiomyopathy type 1: a light on molecular mechanismsN-cadherin/catenin complex as a master regulator of intercalated disc functionTitin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathyThe ARVD/C genetic variants database: 2014 updateMechanistic basis of desmosome-targeted diseasesRecurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasiaGenetics of sudden cardiac death syndromesNew functions for alpha-catenins in health and disease: from cancer to heart regenerationImaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathyArrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonanceA predictive model for canine dilated cardiomyopathy-a meta-analysis of Doberman Pinscher dataArrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment.Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.Arrhythmogenic Cardiomyopathy: Electrical and Structural PhenotypesThe Genetic Challenges and Opportunities in Advanced Heart FailureThe electrocardiographic manifestations of arrhythmogenic right ventricular dysplasiaArrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management.Desmosomal molecules in and out of adhering junctions: normal and diseased States of epidermal, cardiac and mesenchymally derived cells.Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathyDesmin mutations and arrhythmogenic right ventricular cardiomyopathyMolecular signatures of cardiac defects in Down syndrome lymphoblastoid cell lines suggest altered ciliome and Hedgehog pathways.In vitro functional analyses of arrhythmogenic right ventricular cardiomyopathy-associated desmoglein-2-missense variationsThe role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers.Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathy.Dsp rul: a spontaneous mouse mutation in desmoplakin as a model of Carvajal-Huerta syndrome.Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations.Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasiaGenetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome.Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomLoss of αT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemiaExome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac DeathAnalysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability.Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnosesTransgenic mice overexpressing desmocollin-2 (DSC2) develop cardiomyopathy associated with myocardial inflammation and fibrotic remodeling.
P2860
Q24304113-95D40274-97C6-41B3-98BC-C5428028ED97Q26753099-65D48005-8399-43C4-A005-2AB3E2CA141CQ27024037-9860D081-A7C5-4CC2-8760-47BBF90E8673Q27024101-2F8546B2-632B-42AC-97FD-BB275D861EEFQ27690277-8794831A-9E73-4B24-BDB6-DBC70BA847C1Q28238884-EB5CFEE7-C467-48E8-9E48-27FDDE662266Q28246696-C32C5C50-7765-4E07-AFC3-7EB29171E475Q28256845-5740BEB0-A4BF-4C02-97C1-5237E5F7795EQ28295898-92C69294-E7A5-4AA9-8E43-FD984C9967D5Q28304979-12E5AC0E-2559-4A42-9BFB-8B9937517B56Q28307856-C6FF82BC-D892-4152-9E8F-FBF22E23D32DQ28395671-0C8E1291-2E5E-4CAA-ACB6-CCF73333B1F2Q30473247-7839865E-B46C-4EE8-B776-1315A99597A0Q30537711-52C54801-A00D-4FF8-B9F9-0E087CBD60F9Q30921964-D75C4D25-635D-4765-8C3D-84A4FC85C224Q33159766-A10C8CF2-894A-42C9-9DBC-7E52E9D7C0B4Q33161666-B6ABD08C-82B1-4AEF-B64B-6CAEC8184AA8Q33166380-92BEA1E4-652F-4D04-94A2-3C965F3B9B3AQ33167672-82375A45-C2E0-48A3-8069-F063D8AB0853Q33653498-B17DD79A-DA65-40E9-BA5B-F085E001A2ABQ33695854-787B8DDB-33E3-411E-AE67-720664102487Q33906065-FC817E03-F9C9-48D9-B1B4-7F51630B664AQ34018943-41D8E9A7-ACD3-4B69-A2D6-01D99A83E7D8Q34212672-FCCECFBB-0494-47C2-A395-92133F72A59DQ34312860-BD6A1F6F-9D74-43AB-AE28-87CCBAABBC73Q34388617-549816A7-22B6-4A0A-9CE7-15FC521D7EEAQ34447898-3416FE9B-3695-4C18-A77B-E1BDD3ED18A7Q34679867-C76062AE-C56F-4264-8862-24496BE3852CQ34930971-2981EC00-D984-448B-B996-E7157FC48839Q35110260-C98207B1-DF33-4A9F-B8B3-B6EED13322F0Q35305484-A64B02D0-70A4-4F76-B515-E435199EC410Q35488614-32CD456D-C505-416D-9BB0-35ADC0FA07AEQ35531136-01846292-5F82-48FE-B981-28C9CB1FE3F6Q35730438-1A222927-257E-4730-9C43-F710E2DDECB2Q35847506-87529041-DA2C-48E5-A934-5D5D52B3199AQ35851556-74BCDA97-4B41-458F-9855-3D056E2A248BQ36018457-AA6754E0-3DE9-4599-AAA2-006F89AC1AFFQ36133730-C66225FC-0D36-49BB-9556-59581870B2C0Q36150947-1C4E664D-A63D-4FC5-9141-587A38CC8C30Q36322072-A5D9DCC6-6150-4181-9B2D-36892CB5583E
P2860
Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@ast
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@en
type
label
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@ast
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@en
prefLabel
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@ast
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@en
P2093
P2860
P50
P1476
Compound and digenic heterozyg ...... ht ventricular cardiomyopathy.
@en
P2093
Alessandra Lorenzon
Alessandra Rampazzo
Andrea Nava
Barbara Bauce
Cristina Basso
Frank Marcus
Gaetano Thiene
Gian Antonio Danieli
Giorgia Beffagna
Jeffrey Saffitz
P2860
P304
P356
10.1016/J.JACC.2009.11.020
P407
P577
2010-02-01T00:00:00Z